Bionime Corporation (TPE:4737)
Taiwan · Delayed Price · Currency is TWD 57.80
+0.20 (0.35%)
Aug 28, 2026, 1:30 PM CST
Bionime Revenue
Bionime had revenue of 426.63M TWD in the quarter ending June 30, 2026, a decrease of -9.55%. This brings the company's revenue in the last twelve months to 1.72B, down -11.64% year-over-year. In the year 2025, Bionime had annual revenue of 1.84B, down -4.92%.
Revenue (ttm)
1.72B
Revenue Growth
-11.64%
P/S Ratio
2.60
Revenue / Employee
3.43M
Employees
500
Market Cap
4.47B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.84B | -95.16M | -4.92% |
| Dec 31, 2024 | 1.93B | 178.18M | 10.15% |
| Dec 31, 2023 | 1.76B | -455.02M | -20.58% |
| Dec 31, 2022 | 2.21B | 360.67M | 19.50% |
| Dec 31, 2021 | 1.85B | 181.34M | 10.87% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| BenQ Medical Technology | 5.44B |
| Formosa Optical Technology | 4.39B |
| St.Shine Optical | 3.73B |
| Pacific Hospital Supply | 2.42B |
| Bioteque | 2.22B |
| Nang Kuang Pharmaceutical | 2.11B |
| ICARES Medicus | 1.21B |
| SciVision Biotech | 889.15M |